Experts suggest about 3/4s of proposed funds will go to subsidizing corporations, including many firms, which will reap billions from new and increased road tolls, admission fees, bigger bills for water, gas and electricity. This is the gift that keeps giving to crony capitalists. First $750 billion, then guaranteed annual windfalls.
Named “public – private partnerships”, there is nothing public about them, except outcry wherever they have been instituted.
The average American could care less who is the President or which party has control of Congress, but everyone who watches the news is confused about what Donald Trump really believes.
The only sure and consistent Trump initiative has been the 2018 Budget to cut taxes for big corporations – dropping their income tax support of public services from 35% to 21% of profits, and introducing a territorial system so that U.S. companies’ overseas earnings will be taxed at 0%. On the other hand, retirees will continue to pay income tax on their earned Social Security benefits.
Just read another article about Russian collusion, this one on Monday in Vox about why there might, possibly, circumstantially be something dangerous or suspicious in past contacts between the Donald Trump Presidential campaign or its members or associates and anyone who ever knew or worked for Vladimir Putin.
It’s tiring to read the same old litany about why Trump beat Hillary Clinton, and you might conclude “what difference, at this point, does it make,” as she once noted.
But it does make a big difference to the giant in the room – China!
A popular blood thinner now costs U.S. Medicare patients and insurers more than $5,000 a year. This drug, which has amassed sales of more than $10 billion, uses Rivaroxaban as the main ingredient – a compound available from 26 manufacturers in China.
When you check prices for Rivaroxaban for sale in the U.S., the cost of a 10, 15 or 20 mg tablet is virtually identical, so the product quantity is not an issue. Rivaroxaban tablets sold in America, by the way, are so small they are almost impossible to cut in half to make a 20 mg tablet into two tens. Wonder why?
Since the price of materials is obviously so low (two for the price of one), it would seem that where it is manufactured is not very important, but to pencil-poking plutocrats, a penny saved is a salivating savings event of graphite proportions.
But what is the danger from manufacturing our drugs in China?